Vienna strengthens its pioneering role in ME/CFS research and care
City of Vienna, WWTF and WE&ME Foundation: Around €2 million for Austria’s largest ME/CFS research projects to date – PAIS outpatient clinic from 2027
Vienna (OTS) – Two years ago, Vienna began specifically funding research into ME/CFS. Today, the results are becoming clear: The Vienna Science and Technology Fund (WWTF), together with the WE&ME Foundation, is awarding two Consolidation Grants of around one million euros each—the largest individual grants for ME/CFS research in Austria to date.
Mayor Michael Ludwig presented the projects today, Tuesday, together with WWTF President Michael Häupl and Gerhard Ströck, a board member of the WE&ME Foundation, in the ballroom of Vienna City Hall. Since 2024, the WWTF and the WE&ME Foundation have jointly provided around €3.1 million for ME/CFS research in Vienna. “ME/CFS is not a rare disease,” Ludwig stressed.
An estimated 70,000 to 80,000 people in Austria are affected—more than have multiple sclerosis. Around 60 percent of those affected are partially unable to work, and about a quarter are housebound or bedbound. Yet little research has been conducted into the condition. “This is exactly where the city steps in.
Where knowledge is lacking, research must begin. For us, health means both excellent research and care that reaches people,” the mayor said.
New researchers in a neglected field
The WWTF can act quickly and target funding where others have left gaps, explained WWTF President Michael Häupl. “ME/CFS was one such gap: many people affected, hardly any research, hardly any funding.” Seven exploratory projects in 2024 (€700,000) were followed by the establishment of an ME/CFS biobank at the Medical University of Vienna in 2025 (€200,000), six fellowships for early-career researchers in 2026 (€233,000), and now the two Consolidation Grants.
One goal from the outset was to ensure that ME/CFS would not be a scientific dead end for researchers. “We wanted to bring new people into this field. We have succeeded: before our first funding round, neither of the project leaders receiving grants had any connection to ME/CFS. Today, they and their teams are among the most active groups in Austria,” Häupl said.
The projects were selected by an international panel of experts. One notable first in the funding process was that researchers living with the illness, from the international Science4ME Forum, took part in the review as patient experts.
Philanthropic commitment rooted in personal experience
The WE&ME Foundation, established by the Ströck family, grew out of personal experience—two of the family’s adult sons have ME/CFS—and the realisation that patients and their families had few places to turn, little access to diagnostics, and little research that could change this, Gerhard Ströck explained. The family therefore decided to focus on basic research aimed at uncovering the disease’s central mechanisms while also taking the people affected seriously. “The WWTF brings something a foundation cannot provide on its own: experience with funding procedures, international peer review and transparent selection. For our donors, that means every euro goes to research that meets international standards,” Ströck said.
From a pilot project to a major undertaking
Lukas Haider of the Medical University of Vienna then described how an initial project grant developed into a long-term project. He originally worked in multiple sclerosis research. “ME/CFS still has no established biomarker and no causal treatment. Without targeted funding, no one enters this field, because there is no prior work to build on. The WWTF funded exactly that groundwork,” Haider said.
In the pilot project, his team found indications that, under controlled oxygen deprivation, the energy supply in the brains and muscles of ME/CFS patients fails, while healthy people are able to compensate. The new project, ME-RESET (Lukas Haider, Martin Krššák, Kathrin Kollndorfer; 36 months, €999,930), will determine exactly where this failure occurs, whether it is due to blood flow or the mitochondria, and whether it can be partially reversed by supplying oxygen. Patients will be examined in a randomised study using multiorgan MRI, MR spectroscopy and blood markers. The project focuses on a disease mechanism, not a finished treatment.
The second project (Matthias Wielscher, Kathryn Hoffmann; 36 months, €999,169) will investigate whether some people diagnosed with ME/CFS actually have a previously undetected rare genetic disease. The team will establish an Austrian cohort and study it using whole-genome sequencing. A new “ME/CFS Rare Disease Board” will assess the findings. The aim is to improve diagnostic precision.
The Medical University of Vienna as a central hub
“It is important to us to bring basic research together with relevance for patients. This requires an environment where clinical medicine and basic research work directly with one another. We have that here,” said Michaela Fritz, Vice-Rector for Research and Innovation at the Medical University of Vienna. Since September 2024, the Medical University of Vienna has also been home to the National Reference Centre for Post-Viral Syndromes, which provides information to healthcare professionals throughout Austria on behalf of the Ministry of Health. It is led by Eva Untersmayr-Elsenhuber and Kathryn Hoffmann.
About the projects:
Life Sciences
wwtf.at
Life Sciences
wwtf.at
From 2027: PAIS centre in Vienna
With the PAIS Centre, the Vienna Health Association is establishing a specialised point of contact for people with post-acute infection syndromes (PAIS), such as Post-COVID and ME/CFS. “Until now, people affected often had to actively search for doctors who knew about the condition. The centre will be Vienna’s first specialised point of contact. Initially, it will focus on diagnosis, symptom management and support,” said Michael Binder, Medical Director of the Vienna Health Association.
Care is due to begin in summer 2027 in an initial phase, with the centre becoming fully operational in its final phase from mid-2028. It will bring together medical care and therapeutic support based on current guidelines.
“Vienna is supporting important research and helping people affected here on the ground. With the PAIS Centre, research, expertise and care will come together at one location in Vienna,” Mayor Ludwig said in closing.
About ME/CFS
ME/CFS (myalgic encephalomyelitis/chronic fatigue syndrome) is a severe neuroimmunological multisystem disease that the WHO has classified as a neurological disease since 1969 (ICD G93.3). Its core symptom is post-exertional malaise (PEM): even minor physical or mental exertion can cause a significant worsening of a person’s condition, usually with a delay of 24 to 72 hours. Activation or exercise can worsen the illness; pacing—adjusting activity to manage available energy—is recommended. ME/CFS often develops after viral infections, including COVID-19. There is currently no causal treatment.
Media enquiries and contact
Bernhard Muttenthaler
Press Office of Mayor Ludwig
bernhard.muttenthaler@wien.gv.at
Tel.: +43 1 4000 81857
Therese Aigner
Press Relations, WWTF
therese.aigner@wwtf.at
Elena Reghenzani
Corporate Communications, Vienna Health Association
elena.reghenzani@gesundheitsverbund.at
Tel.: +43 1 404 09-60 543